Nasdaq Path News Today

UiPath Inc. (NASDAQ:PATH – Get Rating) has been given an average rating of “Hold” by the twenty-two analysts that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the company. The average 12-month […]

Several analysts have recently updated their ratings and price targets for UiPath (NASDAQ: PATH): 6/2/2022 – UiPath had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $23.00. They now have a “buy” rating on the stock. 6/2/2022 – UiPath had its price target lowered by analysts at BMO Capital Markets […]

UiPath (NASDAQ:PATH – Get Rating) had its price target reduced by research analysts at Evercore ISI from $28.00 to $23.00 in a research note issued to investors on Thursday, The Fly reports. Evercore ISI’s price objective indicates a potential upside of 36.66% from the stock’s current price. PATH has been the topic of several other […]

UiPath (NASDAQ:PATH – Get Rating) had its price target cut by Credit Suisse Group from $57.50 to $45.00 in a research report issued to clients and investors on Thursday, The Fly reports. Credit Suisse Group’s target price indicates a potential upside of 167.38% from the stock’s current price. Several other research firms have also recently […]

UiPath (NASDAQ:PATH – Get Rating) had its price objective cut by equities research analysts at Truist Financial from $55.00 to $45.00 in a research report issued to clients and investors on Thursday, The Fly reports. Truist Financial’s target price would suggest a potential upside of 143.51% from the stock’s current price. Several other equities research […]

UiPath (NASDAQ:PATH – Get Rating) had its target price dropped by equities researchers at BMO Capital Markets from $29.00 to $21.00 in a report issued on Thursday, The Fly reports. BMO Capital Markets’ price objective would indicate a potential upside of 7.64% from the company’s previous close. A number of other research firms also recently […]

UiPath (NASDAQ:PATH – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in New […]

UiPath (NASDAQ:PATH – Get Rating) had its target price cut by stock analysts at KeyCorp from $34.00 to $23.00 in a report issued on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare company’s stock. KeyCorp’s price objective would indicate a potential upside of 28.13% from the company’s previous close. Several […]

UiPath (NASDAQ:PATH – Get Rating) and ANSYS (NASDAQ:ANSS – Get Rating) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk. Profitability This table compares UiPath and ANSYS’s net margins, return on […]

UiPath (NASDAQ:PATH – Get Rating) is one of 403 publicly-traded companies in the “Prepackaged software” industry, but how does it contrast to its peers? We will compare UiPath to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, profitability, earnings, dividends and valuation. Analyst Ratings This is a summary of recent […]